Replicate Bioscience
San Diego, CA
Replicate Bioscience creates novel oncology treatments to prevent and reverse drug resistance through a self-replicating RNA platform called SynRGY. By deploying SynRGY technology, the company aims to design novel treatments that prevent the occurrence of drug resistance and create solutions that enhance the effectiveness of many immuno-oncology regimens.
replicatebioscience.comCompany Details
Founded
- 2021
Employees
- Between 20 - 50 employees
Raised
- $46,000,000
Headquarters Location
- San Diego, CA
Public
- No
Acquired
- No
CEO
- Nathaniel Wang
Founders
- Nathaniel WangAndrew GeallMichael EhlersZachary HartmanHerbert Kim Lyerly
Company Collections
These are collections Replicate Bioscience is a part of. Click on the collection name to view similar companies.